Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 29/08/20061 min de lecture
Cardiovascular and Renal Drugs Advisory Committee; Amendment of Notice
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Cardiovascular and Renal Drugs Advisory Committee. This meeting was originally announced in the Federal Register of August 1, 2006 (71 FR 43487). The amendment is being made to reflect changes in the Agenda portion of the document. The word "TRASYOL" should read "TRASYLOL". In the same paragraph, the word "apportioning" should read "aprotinin". There are no other changes.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →